2023年6月16日

索菲婭遺傳學技術艾滋病遊牧遺傳學發展的癌症研究能力索菲亞遺傳學(納斯達克:大學二年級生),原生雲軟件公司在醫療領域和醫學數據驅動的領導者,今天宣布了一項戰略聯盟與遊牧遺傳學。總部位於墨西哥城和智利、遊牧是一個創新的實驗室以其專業化在基因組學和臨床研究。通過無縫部署索菲亞遺傳學的開拓索菲亞DDM™平台,遊牧遺傳學是增加其研究能力,提高其運作效率。索菲亞DDM™平台,以其複雜的分析能力,將裝備遊牧遺傳學解釋複雜的基因數據的能力,從而使更多的熟練和廣泛的基因組在拉丁美洲地區和臨床研究。這種合作標誌著一個重要的飛躍精密醫學擴大視野,加強索菲亞民主化數據驅動的醫學遺傳學的堅定承諾。“在遊牧遺傳學,我們努力讓每個病人精密醫學通過我們先進的技術和特定基因組麵板每個類型的癌症,”Guillermo Cordero說遊牧遺傳學CEO。“在遊牧遺傳學,我們努力改變病人護理的提供個性化的精密醫學。利用我們的尖端技術和定製基因組板適合每一個獨特的癌症類型,我們努力推進醫藥保健的界限。“HRD是由細胞的能力受損通過同源重組修複DNA雙鏈斷裂修複(嗯)通路,與某些癌症的發展,包括先進的卵巢癌,乳腺癌,前列腺癌、胰腺癌。對於那些患有這些癌症類型,HRD可以作為潛在的治療response1預測生物標誌物。 Testing for HRD can produce a vast set of complex data that is both time-intensive and costly to analyze. With the SOPHiA GENETICS Platform, laboratories like NOMAD Genetics can quickly obtain interpreted results, creating increased efficiencies for clinical researchers. In addition, SOPHiA GENETICS allows NOMAD Genetics to retain full ownership of their data, saving time and expense, while offering comprehensive genomic insights powered by deep learning algorithms. “Our products and solutions are designed to enable facilities like NOMAD Genetics to more easily advance precision-medicine,” said Ricardo Mendonca Filho, PhD, Managing Director, LAPAC, SOPHiA GENETICS. “By leveraging our technology, NOMAD Genetics can expedite their clinical research, enabling them to make informed, data-driven decisions for LATAM with greater efficiency.” Through the implementation of the SOPHiA GENETICS Platform, NOMAD Genetics will be able to more quickly and accurately identify HRD-positive cancers and utilize a streamlined workflow that will help accelerate rare and inherited disease research. For more information on SOPHiA GENETICS, visit SOPHiAGENETICS.COM, or connect on Twitter, LinkedIn, Facebook, and Instagram. To learn more about NOMAD Genetics, visit nomadlaboratorios.com, or connect on Twitter, LinkedIn, Facebook, and Instagram. previous post